BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22010990)

  • 21. Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura.
    Gu J; Lu L; Xu R; Chen X
    Chin Med J (Engl); 2002 Jul; 115(7):983-6. PubMed ID: 12150725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A patient with idiopathic thrombocytopenic purpura presenting with an acute ischemic stroke.
    Theeler BJ; Ney JP
    J Stroke Cerebrovasc Dis; 2008; 17(4):244-5. PubMed ID: 18589347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial ischemia in a patient with chronic refractory idiopathic thrombocytopenic purpura.
    Koch CA; Archer TP; Kraut EH
    Arch Intern Med; 1997 Dec 8-22; 157(22):2668. PubMed ID: 9531242
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal hepatitis C in the absence of detectable serum or hepatic virus.
    Fowell AJ; Sheron N; Rosenberg WM
    Liver Int; 2008 Jul; 28(6):889-91. PubMed ID: 18647143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.
    Olsson B; Andersson PO; Jernås M; Jacobsson S; Carlsson B; Carlsson LM; Wadenvik H
    Nat Med; 2003 Sep; 9(9):1123-4. PubMed ID: 12937414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
    Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
    Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
    Gernsheimer T
    Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measurement of reticulated platelet using whole blood: methodology and clinical application].
    Nishiyama M; Hayashi S; Futsukaichi Y; Suehisa E; Kurata Y
    Rinsho Byori; 2000 Sep; 48(9):872-6. PubMed ID: 11051807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
    McFarland J
    Blood Rev; 2002 Mar; 16(1):1-2. PubMed ID: 11913982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet microparticles in immune thrombocytopenic purpura in pediatrics.
    Tantawy AA; Matter RM; Hamed AA; Shams El Din El Telbany MA
    Pediatr Hematol Oncol; 2010 May; 27(4):283-96. PubMed ID: 20426519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced antioxidant capacities in platelets from patients with autoimmune thrombocytopenia purpura (ITP).
    Kamhieh-Milz J; Bal G; Sterzer V; Kamhieh-Milz S; Arbach O; Salama A
    Platelets; 2012; 23(3):184-94. PubMed ID: 21913810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center.
    Zhang L; Li H; Zhao H; Ji L; Yang R
    Eur J Haematol; 2003 Mar; 70(3):196-7. PubMed ID: 12605667
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of myeloid human cytomegalovirus infection in children's idiopathic thrombocytopenic purpura.
    Ding Y; Zhao L; Mei H; Zhang SL; Huang ZH
    Pediatr Hematol Oncol; 2007; 24(3):179-88. PubMed ID: 17454787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
    Wang L; Li Y; Hou M
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of platelet-associate autoantibodies against platelet-specific receptors by cytometric bead array and its clinical application in idiopathic thrombocytopenic purpura].
    Liu XG; Wang YM; Hou M; Zhang T; Zhu YY; Peng J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):175-8. PubMed ID: 18788617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome.
    de Almeida AJ; Campos-de-Magalhães M; Brandão-Mello CE; de Oliveira RV; do Espirito-Santo MP; Yoshida CF; Lampe E
    Hepatogastroenterology; 2009; 56(90):429-36. PubMed ID: 19579615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura.
    Asahi A; Kuwana M; Suzuki H; Hibi T; Kawakami Y; Ikeda Y
    Haematologica; 2006 Oct; 91(10):1436-7. PubMed ID: 16963398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
    Pockros PJ; Duchini A; McMillan R; Nyberg LM; McHutchison J; Viernes E
    Am J Gastroenterol; 2002 Aug; 97(8):2040-5. PubMed ID: 12190174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement-mediated fragmentation and lysis of opsonized platelets: ender differences in sensitivity.
    Horstman LL; Jy W; Schultz DR; Mao WW; Ahn YS
    J Lab Clin Med; 1994 Apr; 123(4):515-25. PubMed ID: 8145000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet antibodies and their correlation with clinical findings in childhood immune thrombocytopenic purpura.
    Yildirmak Y; Yanikkaya-Demirel G; Palanduz A; Kayaalp N
    Acta Haematol; 2005; 113(2):109-12. PubMed ID: 15802889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.